MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer
MYC是乳腺癌中mTOR抑制剂耐药性的一个具有临床意义的驱动因素。
期刊:Journal of Experimental Medicine
影响因子:12.6
doi:10.1084/jem.20211743
Jinhyuk Bhin # ,Julia Yemelyanenko # ,Xue Chao ,Sjoerd Klarenbeek ,Mark Opdam ,Yuval Malka ,Liesbeth Hoekman ,Dinja Kruger ,Onno Bleijerveld ,Chiara S Brambillasca ,Justin Sprengers ,Bjørn Siteur ,Stefano Annunziato ,Matthijs J van Haren ,Nathaniel I Martin ,Marieke van de Ven ,Dennis Peters ,Reuven Agami ,Sabine C Linn ,Epie Boven ,Maarten Altelaar ,Jos Jonkers ,Daniel Zingg ,Lodewyk F A Wessels